Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 23

Trial Status

Completed3
Other1

Role Distribution

Principal Investigator3
Other Roles1
PI Rate75%

Activity Timeline

Clinical Trials (4)

NCT00183339Phase 2Completed
Early Intervention With Fluoxetine in Autism
Autistic Disorder
Studychair
NCT01006551Phase 2Completed
Ziprasidone in Early Onset Schizophrenia Spectrum Disorders
Schizophrenia
Principalinvestigator
NCT01731119Phase 2Completed
Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents
Asperger SyndromeAutistic DisorderBipolar I Disorder+10 more
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Sabine Hazan, MD

ProgenaBiome

Related
41 trials

Shared therapeutic areas:

Autistic DisorderAutism Spectrum DisorderBipolar I Disorder+1 more
Similarity Score9%

Robert B Innis, M.D.

National Institute of Mental Health (NIMH)

Related
35 trials

Shared therapeutic areas:

Autistic DisorderAutism Spectrum DisorderSchizophrenia

Worked with same sponsors:

National Institute of Mental Health (NIMH)
Similarity Score6%

Forbes D Porter, M.D.

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Related
15 trials

Shared therapeutic areas:

Asperger SyndromeAutistic DisorderAutism Spectrum Disorder
Similarity Score6%

Barbara B Biesecker

National Human Genome Research Institute (NHGRI)

Related
23 trials

Shared therapeutic areas:

Asperger SyndromeAutistic DisorderAutism Spectrum Disorder
Similarity Score6%

Antonio Hardan, MD

Stanford University

Related
12 trials

Shared therapeutic areas:

Autistic DisorderAutism Spectrum Disorder
Similarity Score4%

Jean-Olivier ARNAUD, Director

Assistance Publique Hôpitaux de Marseille

Related
17 trials

Shared therapeutic areas:

Bipolar I DisorderSchizophrenia
Similarity Score4%

James McCracken, MD

University of California, Los Angeles

Related
8 trials

Shared therapeutic areas:

Autism Spectrum DisorderAutistic Disorder

Worked with same sponsors:

National Institute of Mental Health (NIMH)
Similarity Score4%

Susan Shur-Fen Gau, MD, PhD

National Taiwan University Hospital & College of Medicine

Related
23 trials

Shared therapeutic areas:

Autism Spectrum DisorderAutistic Disorder
Similarity Score4%

Sanjeev Pathak, MD

Alkermes, Inc.

Related
13 trials

Shared therapeutic areas:

Schizophrenia
Similarity Score2%

Suman Sheraz, PhD*

Riphah International University

Related
21 trials

Shared therapeutic areas:

Autism Spectrum Disorder
Similarity Score2%

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT00183339Phase 2StudyChair

Early Intervention With Fluoxetine in Autism

Autistic Disorder
Completed
NCT01006551Phase 2PrincipalInvestigator

Ziprasidone in Early Onset Schizophrenia Spectrum Disorders

Schizophrenia
Completed
NCT01731119Phase 2PrincipalInvestigator

Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents

Asperger SyndromeAutistic DisorderBipolar I Disorder+10 more
Completed
NCT02353130PrincipalInvestigator

Cortical Metrics Assessment Outcome Measure Development in Autism With Memantine Treatment

Autism Spectrum Disorders
Withdrawn

All 4 trials loaded